RecruitingNot ApplicableNCT07723209

Radiation After No Axillary Nodal Sampling

RADIation After no Axillary Nodal Sampling (RADIANS)


Sponsor

NYU Langone Health

Enrollment

105 participants

Start Date

Jul 9, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This is a single arm, pilot, prospective study to evaluate the safety of partial breast irradiation in women who undergo breast conserving surgery without sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND). Baseline demographic and clinical information will be collected. All patients will complete the Breast Cancer Treatment Outcome Scale (BCTOS-13) questionnaire and the Functional Assessment of Chronic Illness Therapy-Comprehensive Score for financial Toxicity at baseline and at 2 years. All patients are required to have an axillary ultrasound prior to radiation start if this was not obtained pre-operatively.


Eligibility

Sex: FEMALEMin Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Partial Breast Irradiation (PBI) for people with early stage breast cancer and invasive ductal carcinoma of female breast. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 40 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONPartial Breast Irradiation (PBI)

Delivered using 3D or 3D/IMRT or IMRT techniques following breast-conserving surgery.


Locations(1)

NYU Langone Health

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07723209


Related Trials